Progyny Inc (PGNY) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States.

Total Cash From Operating Activities Chart for Progyny Inc

Progyny Inc (PGNY) operating cash flow for FY2025 was USD 210.2M, a 17.4% change from FY2024. Progyny Inc's operating cash flow moved from USD -9.5M in 2017 to USD 210.2M in 2025 over 8 years. Operating cash flow compound annual growth rate: 5-year CAGR of 42.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$2.22B
Implied Share Price
$28.97
Enterprise Value
$1.49B
Revenue (TTM)
$1.31B
EBITDA
$125.57M
Profit Margin
6.00%
Trailing P/E
31.49
Forward P/E
10.43
Price/Book (MRQ)
3.43
Price/Sales (TTM)
1.70
EV/EBITDA
18.41
EV/Revenue
1.20
Dividend Yield
—
Book Value
$5.90
Free Cash Flow (FY2025)
$191.78M
Free Cash Flow Yield
8.63%

Snapshot as of 25th October 2026 — not point-in-time controlled, may lag the live market by a few days.